###begin article-title 0
###xml 111 115 111 115 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">kip1</sup>
###xml 62 67 <span type="species:ncbi:9606">human</span>
PKC alpha affects cell cycle progression and proliferation in human RPE cells through the downregulation of p27kip1
###end article-title 0
###begin title 1
Purpose
###end title 1
###begin p 2
###xml 237 242 <span type="species:ncbi:9606">human</span>
Protein kinase C (PKC) plays an important role in the regulation of retinal pigment epithelium (RPE) cell proliferation. In this study, we investigated which of these isozymes could be responsible for the cell cycle and proliferation in human RPE cells.
###end p 2
###begin title 3
Methods
###end title 3
###begin p 4
###xml 399 404 399 400 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 32 37 <span type="species:ncbi:9606">human</span>
The effect of PKC activators on human RPE cell cycle progression was tested by flow cytometry. To identify the isoform of PKC responsible for the increased progression of the cells through the cell cycle, we monitored the effect of phorbol 12-myristate 13-acetate (PMA) on the subcellular localization of the nine PKC isoforms expressed in RPE cells. To evaluate the molecular mechanism by which PKCalpha induces cell cycle progression, we examined the transcript, protein, and cellular levels of cell cycle regulatory proteins using RT-PCR, western blotting, and a confocal microscope, respectively.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 158 163 158 159 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 278 283 274 275 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 450 455 442 443 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 517 521 505 509 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">kip1</sup>
We demonstrated that PKC activation by PMA affected cell cycle progression in RPE cells. Of the nine PKC isoforms that were present in RPE cells, we found PKCalpha was both necessary and sufficient to promote cell cycle progression after being stimulated with PMA. Decreased PKCalpha expression resulted in a significant decrease in cell proliferation. The only cell cycle-regulatory molecule whose expression was rapidly altered and decreased by PKCalpha activity was the cyclin- dependent kinase (CDK) inhibitor p27kip1.
###end p 6
###begin title 7
Conclusions
###end title 7
###begin p 8
###xml 30 35 30 31 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 137 141 133 137 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">kip1</sup>
###xml 88 93 <span type="species:ncbi:9606">human</span>
These results suggest that PKCalpha affects cell cycle progression and proliferation in human RPE cells through the downregulation of p27kip1.
###end p 8
###begin title 9
Introduction
###end title 9
###begin p 10
###xml 308 309 308 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 310 311 310 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 477 478 477 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 479 480 479 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 609 614 609 610 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 619 624 615 617 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;I</sub>
###xml 629 635 622 625 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;II</sub>
###xml 644 649 634 635 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</sub>
###xml 779 784 765 766 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#948;</sub>
###xml 789 796 771 772 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;</sub>
###xml 801 804 777 778 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#951;</sub>
###xml 809 814 783 784 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#952;</sub>
###xml 832 834 802 803 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</sub>
###xml 836 837 805 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
###xml 932 936 901 902 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#950;</sub>
###xml 941 947 907 908 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#955;</sub>
###xml 955 959 916 917 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#953;</sub>
###xml 1248 1249 1206 1207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 1250 1251 1208 1209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
Protein kinase C (PKC) is a multigene family of phospholipid-dependent serine-threonine kinases that mediates the phosphorylation of numerous protein substrates in signal transduction. It plays a central role in cellular processes such as proliferation, differentiation, mitosis, and inflammatory reactions [1,2]. Up to now, at least 12 isoforms of PKC have been cloned to date, all displaying different enzymatic properties, tissue expression, and intracellular localization [3,4]. PKCs are divided into three major groups according to the variability of their regulatory domains. The classic PKCs (cPKC: PKCalpha, PKCbetaI, PKCbetaII, and PKCgamma) require calcium, phosphatidylserine, and diacylglycerol (DAG), or phorbol esters, for full activation. The novel PKCs (nPKC: PKCdelta, PKCepsilon, PKCeta, PKCtheta, and probably PKCmu [5]) do not require calcium or their activation. The third group are the atypical PKCs (aPKC: PKCzeta, PKClambda and PKCiota), whose activation depends on phosphatidylserine, but not on DAG, nor on calcium or phorbol esters. The differences in function of specific PKC isoforms are mainly due to their subcellular localization, their activation or inhibition by different stimuli, and transcriptional regulation [6,7].
###end p 10
###begin p 11
###xml 183 184 183 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 185 187 185 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 520 521 520 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 633 635 633 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 756 758 756 758 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 775 777 775 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 911 913 911 913 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 914 916 914 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 1015 1017 1015 1017 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 1263 1265 1263 1265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 1380 1385 1380 1381 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 1390 1395 1386 1388 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;I</sub>
###xml 1400 1406 1393 1396 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;II</sub>
###xml 1411 1416 1401 1402 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#948;</sub>
###xml 1421 1428 1407 1408 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;</sub>
###xml 1433 1438 1413 1414 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#952;</sub>
###xml 1443 1445 1419 1420 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</sub>
###xml 1450 1454 1425 1426 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#950;</sub>
###xml 1459 1465 1431 1432 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#955;</sub>
###xml 1474 1478 1441 1442 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#953;</sub>
###xml 1522 1524 1486 1488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 1784 1789 1748 1749 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 1936 1940 1896 1900 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">kip1</sup>
###xml 780 786 <span type="species:ncbi:9986">Rabbit</span>
###xml 1505 1510 <span type="species:ncbi:9606">human</span>
###xml 1735 1740 <span type="species:ncbi:9606">human</span>
It has been well documented that the PKC family is involved in the processes of proliferation, migration, phagocytosis, and gel contraction in retinal pigment epithelium (RPE) cells [8-14], which have all been implicated in the pathogenesis of proliferative vitreoretinopathy (PVR). For example, Harris et al. reported that hypericin, a specific inhibitor of PKC, could have potential as a therapeutic drug for PVR and that its antiproliferative and apoptotic effects on RPE cells in vitro were in part mediated by PKC [9]. Another study showed that the PKC inhibitor calphostin C dramatically affected the growth rate of RPE cells [10]. We have found that hypericin has potential as a therapeutic drug for PVR, potentially through its inhibition of the Ca2+ influx pathway [15]. Rabbit models have shown that intravitreal injection of hypericin is also a safe and effective means of reducing experimental PVR [16,17]. However, since the distribution of PKC isoforms is both tissue-specific and cell type-specific [18], the PKC activity is the sum of the isoforms expressed in that tissue. Therefore, data regarding the precise pattern of isoform expression in RPE cells could be informative with regard to their physiologic regulation and potential role in PVR [19]. Our previous study characterized the expression pattern of all 12 PKC isoforms and showed that ten isoforms (PKCalpha, PKCbetaI, PKCbetaII, PKCdelta, PKCepsilon, PKCtheta, PKCmu, PKCzeta, PKClambda, and PKCiota) were present in cultured human RPE cells [20]. This identification provides the first step toward elucidating their roles in RPE cell proliferation. In this study, we further investigated which of these isozymes could be responsible for the cell cycle in human RPE cells. Our results demonstrate that PKCalpha controls proliferation and regulates cell cycle progression in RPE cells through the downregulation of cyclin-dependent kinase (CDK) inhibitor p27kip1.
###end p 11
###begin title 12
Methods
###end title 12
###begin title 13
Reagents
###end title 13
###begin p 14
###xml 432 437 423 424 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 442 447 429 430 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</sub>
###xml 452 457 435 436 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#948;</sub>
###xml 462 469 441 442 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;</sub>
###xml 474 477 447 448 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#951;</sub>
###xml 482 487 453 454 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#952;</sub>
###xml 492 496 459 460 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#953;</sub>
###xml 505 511 469 470 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#955;</sub>
###xml 584 589 543 545 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;I</sub>
###xml 594 600 550 553 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;II</sub>
###xml 605 609 558 559 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#950;</sub>
###xml 618 620 568 569 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</sub>
###xml 833 838 779 780 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 273 279 <span type="species:ncbi:9986">Rabbit</span>
Trizol reagent was obtained from Life Technologies (Gaithersburg, MD). The SuperScripttrade mark first strand synthesis system was obtained from Invitrogen (Carlsbad, CA). The enhanced chemiluminescence (ECL) kit for western blotting was from Cell Signaling (Danvers, MA). Rabbit polyclonal antibodies against p27 and phorbol 12-myristate 13-acetate (PMA) were obtained from Santa Cruz Biotechnology (Santa Cruz, CA). Monoclonal PKCalpha, PKCgamma, PKCdelta, PKCepsilon, PKCeta, PKCtheta, PKCiota, and PKClambda antibodies were purchased from BD Systems (Torrance, CA). Monoclonal PKCbetaI, PKCbetaII, PKCzeta, and PKCmu antibodies were from Sigma (St. Louis, MO). Anti-beta actin was purchased from Boster Biologic Technology, LTD (Wuhan, China). Thymeleatoxin was from Biovision (Mountain View, CA). Small-interference (si) RNA-PKCalpha was obtained from Ruibo Biotech (Guangzhou, China). Lipofectamine 2000 was purchased from Invitrogen.
###end p 14
###begin title 15
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human RPE cell culture
###end title 15
###begin p 16
###xml 182 184 182 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 40 45 <span type="species:ncbi:9606">human</span>
###xml 798 804 <span type="species:ncbi:9913">bovine</span>
Human RPE cells were isolated from five human donors, age 23 to 40 years, within 24 h after death, which were obtained from the Zhongshan Ophthalmic Center, as previously described [20]. This project was approved by the Ethics Committee of the Zhongshan Ophthalmic Center, and followed the tenets of the Declaration of Helsinki. Briefly, the anterior segment, vitreous and neurosensory retina were removed and an eye cup was made. The RPE cells were immersed in a trypsin (0.05%)-EDTA (0.02%) solution at 37 degreesC for 1 h. Culture medium with 20% FBS was added, and the RPE were isolated and collected with a pipette, using a dissecting microscope. Isolated cells were centrifuged, resuspended and seeded to Corning culture plates in Dulbecco's modified Eagle medium (DMEM) containing 10% fetal bovine serum, penicillin G (100 mu/ml), streptomycin sulfate (100 mg/ml), and 2mM L-glutamate in. Experimentation was performed using 70%-80% confluent cells at cell passage 3 to 8.
###end p 16
###begin title 17
Flow cytometry
###end title 17
###begin p 18
###xml 225 226 225 226 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 229 230 229 230 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 232 233 232 233 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 247 248 247 248 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 250 251 250 251 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 279 280 275 276 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 314 315 306 307 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
Confluent RPE cells were stimulated with 100 nM PMA, 100 nM thymeleatoxin and DMEM (as control group) and collected at each time point, then incubated in PBS (8.00 g/l sodium chloride, 0.20 g/l potassium chloride, 1.56 g/l Na2HPO4.H2O, 0.20 g/l KH2PO4) containing 50 microg/ml/106 cells RNase A and 50 microg/ml/106 cells propidium iodide (PI) for 30 min at 37 degreesC. The cell cycle analysis of treated cells at each time point were done on FACScan Flow Cytometer (Becton Dickinson). The red fluorescence (PI) from cells were excited at 488 nm using channel 2. The distribution of cells in different phases of the cell cycle was obtained by analyzing fluorescence intensities with Lysis II software (Becton Dickinson).
###end p 18
###begin title 19
Reverse transcription-polymerase chain reaction
###end title 19
###begin p 20
###xml 515 522 496 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
Total RNA was extracted using Trizol reagent according to the manufacturer's procedure. The integrity of the RNA was checked by 2% agarose gel electrophoresis. Approximately 5 microg RNA was reverse-transcribed following the protocol of the SuperScripttrade mark first-strand synthesis system. cDNAs encoding the cell cycle regulator genes were amplified by PCR as follows: denaturation for 30 s, annealing for 30 s and elongation at 72 degreesC for 60 s. Primer sequences were designed using Primer 3, as shown in Table 1. Each PCR was done a minimum of three times with each set of primers. PCR products were analyzed by agarose (2%) gel electrophoresis and ethidium bromide staining.
###end p 20
###begin title 21
Primers and PCR conditions of cell cycle regulator genes
###end title 21
###begin p 22
RNA (5 microg) was reverse-transcribed following the protocol of the SuperScripttrade mark first-strand synthesis system. cDNAs encoding the cell cycle regulator genes were amplified by PCR as follows: denaturation for 30 s, annealing for 30 s and elongation at 72 degreesC for 60 s. Primer sequences were designed using Primer 3.
###end p 22
###begin title 23
Preparation of cell extracts
###end title 23
###begin p 24
###xml 218 220 218 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 63 68 <span type="species:ncbi:9606">human</span>
The medium was removed and washed twice with ice-cold PBS. The human RPE cells were lysed with sample buffer that contained 60 mM Tris, pH 6.8, 2% (w/v) SDS, 100 mM 2-mercaptoethanol, and 0.01% (w/v) bromophenol blue [21]. The lysates were then incubated on ice for 30 min. The extracts were harvested using a cell scraper, then boiled for 5 min and stored at -20 degreesC.
###end p 24
###begin title 25
Western blot analysis
###end title 25
###begin p 26
###xml 91 93 91 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 33 38 <span type="species:ncbi:9606">human</span>
###xml 578 589 <span type="species:ncbi:3704">horseradish</span>
###xml 990 995 <span type="species:ncbi:10090">mouse</span>
Cellular extracts from confluent human RPE cells were processed for western blot analysis [22]. Briefly, 40 microg of protein per well was loaded on a 12% sodium dodecyl sulfate- PAGE (SDS-PAGE) gel. Protein was electrotransferred to polyvinylidene difluoride membranes (Millipore) for 2 h at 350 mA, then blocked with a solution of Tris-buffered saline (TBS) containing 5% nonfat milk and 0.1% Tween-20 (TBST) for 1 h, and incubated with primary antibodies overnight at 4 degreesC. After three washes with TBST for 10 min at room temperature, the membranes were incubated with horseradish peroxidase-conjugated secondary antibody for 3 h at room temperature, and then washed one time with TBST for 30 min at room temperature. Localization of antibodies was detected by chemiluminescence using an ECL kit following the manufacturer's instructions. Each PKC isoform was examined in a minimum of four independent experiments. As recommended by the supplier of the primary antibodies, we used mouse brain lysate as a positive control.
###end p 26
###begin title 27
Subcellular fractionation
###end title 27
###begin p 28
###xml 110 112 110 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 113 115 113 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
Confluent cells were partitioned into soluble and particulate fractions, using a method previously described [23,24]. Briefly, cells were lysed in digitonin lysis buffer (as described in the previous section, but without Triton X-100) and homogenized for 10 s at 3300x g Digitonin-soluble (cytosolic) and insoluble (particulate) fractions were separated by ultracentrifugation at 100,000x g for 45 min at 4 degreesC. Supernatant was collected, and it formed the cytosolic fraction. The pellet was resuspended in digitonin buffer containing 1% Triton X-100, incubated on ice for 30 min, and cleared by centrifugation for 10 min at 10,000x g at 4 degreesC. Proteins were quantified by the Bio-Rad protein assay. Samples were subjected to SDS-PAGE as described in the previous section; 80 microg of protein were loaded per well.
###end p 28
###begin title 29
Cell proliferation by thymeleatoxin or siRNA-PKCalpha
###end title 29
###begin p 30
###xml 46 47 46 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 413 418 413 414 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 703 708 699 700 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
RPE cells were cultured in 75 mm dishes (10x105 cells/dish) in DMEM and allowed to grow to confluence. Then the cells were incubated with 100 nM thymeleatoxin for 24 h, or transfected with 100 nM siRNA using lipofectamine 2000 according to the manufacturer's protocol, with some modifications. The cells were fed with transfection reagent in serum-free DMEM for 24 h. Three independent siRNAs directed against PKCalpha (A1-A3) were used, along with one control of scrambled siRNA (C): A1, dTd Ggc ugc uga cag aca ucu uu; A2, dCd Acc uac cau guu caa cga au; A3, dTd Acc gca gga caa cau acu uu; C, (product #2005527113152; Ruibo Biotech, Guangzhou, China). The medium containing thymeleatoxin or siRNA-PKCalphawas removed 24 h later.
###end p 30
###begin title 31
Immunofluorescence analysis
###end title 31
###begin p 32
###xml 120 125 120 121 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 382 387 <span type="species:ncbi:9796">horse</span>
Human RPE cells grown on coverslips were stimulated for 24 h with 100 nM PMA, 100 nM thymeleatoxin, and 100 nM siRNA-PKCalpha. They were fixed for 15 min in PBS containing 4% paraformaldehyde, and then rinsed three times in PBS. All reagent incubations were performed in a humidified chamber. The primary antibodies were incubated for 16 h in a solution of PBS at room temperature; horse serum was used as the negative control instead of the primary antibody. After washing four times for 10 min in PBS, FITC and Cy3 -labeled secondary antibodies were incubated for 40 min at 37 degreesC. Then Hoechst 33342 was incubated for 5 min at room temperature. After three rinses in PBS, coverslips were mounted onto glass slides. Slides were analyzed on a Zeiss laser scanning confocal microscope (LSCM510META). Each antibody was used in a minimum of three separate experiments.
###end p 32
###begin title 33
Data and statistical analysis
###end title 33
###begin p 34
Results are expressed as mean +/-standard deviation (SD). Statistical analyses were performed upon comparisons using one-way ANOVA (ANOVA). A value of p<0.05 was considered significant.
###end p 34
###begin title 35
Results
###end title 35
###begin title 36
PKC activation with a phorbol ester affects cell cycle progression
###end title 36
###begin p 37
###xml 128 129 128 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 130 132 130 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 433 444 433 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1A,B</xref>
###xml 737 738 737 738 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 404 409 <span type="species:ncbi:9606">human</span>
Previous work has shown that the PKC inhibitors, hypericin, and calphostin C, dramatically affect the growth rate of RPE cells [9,10]; however, the identity of the PKC isoform involved has remained unclear. To establish which isoform of PKC is potentially involved, we tested the effect of a phorbol ester, PMA, a potent activator of conventional and novel PKC isoforms, on the cell cycle progression of human RPE cells. As shown in Figure 1A,B, after 3 h following the addition of 100 nM PMA, RPE cells entered the S phase. The numbers that entered into S phase at 6, 9, and 12 h time points in PMA-treated RPE cells were decreased when compared with those in the control cells (p<0.05). In contrast, the numbers that entered into the G2-M phases of the cell cycle were increased between 3 and 12 h of treatment, indicating that PMA can slightly affect progression through the cell cycle. By 24 h of treatment, the distribution of the cells between the different phases of the cell cycle was similar to that of the control cells treated only with the vehicle dimethyl sulfoxide. However, control cells showed no significant change in distribution between the different phases of the cell cycle during the 24 h time course examined.
###end p 37
###begin p 38
###xml 113 114 113 114 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 155 156 155 156 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 227 228 227 228 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 263 264 263 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">y</italic>
###xml 304 305 304 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</italic>
###xml 386 387 386 387 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 392 393 392 393 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 479 480 479 480 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 46 51 <span type="species:ncbi:9606">human</span>
PKC activation with PMA affects cell cycle in human RPE cells. Flow cytometry analysis of PMA-treated RPE cells (A) shows decreased S phase and increased G2-M phases cell numbers when compared with that of untreated RPE cells (B). For each side scatter plot, the y-axis is the number of cells, while the x-axis is the DNA content. Values from each scatter plot are graphed below panels A and B. Similar results after PMA treatment were obtained in eight independent experiments. C: Immunofluorescence of cellular DNA stained with propidium iodide (PI) showed cells in interphase or at different stages of mitosis. RPE cells were grown on glass coverslips for 24 h, treated either with PMA or with thymeleatoxin for 9 h, and then fixed.
###end p 38
###begin p 39
###xml 55 56 55 56 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 382 391 382 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1C</xref>
To further confirm that cells were not blocked in the G2 phase, PI-stained RPE cells grown on glass coverslips were analyzed by immunofluorescence microscopy at various times following PMA or vehicle treatment. Cells at all stages of mitosis could be observed in both PMA-treated cells and vehicle-treated cells, indicating that the cells were progressing normally through mitosis (Figure 1C). Therefore, PKC activation seemed to play a role in the regulation of cell cycle progression.
###end p 39
###begin p 40
###xml 305 307 305 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 338 343 338 339 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 351 356 347 348 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#948;</sub>
###xml 426 432 418 421 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;II</sub>
###xml 437 444 426 427 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;</sub>
###xml 449 454 432 433 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#952;</sub>
###xml 459 463 438 439 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#950;</sub>
###xml 477 483 450 451 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#955;</sub>
###xml 492 494 460 461 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</sub>
###xml 521 529 488 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2</xref>
###xml 535 540 502 503 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#948;</sub>
###xml 627 632 590 591 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 818 823 777 778 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 831 836 786 787 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#948;</sub>
###xml 201 206 <span type="species:ncbi:9606">human</span>
To identify the isoform of PKC responsible for the progression of the cells through the cell cycle, we monitored the effect of PMA on the subcellular localization of the nine PKC isoforms expressed in human RPE cells. Translocation of PKC from the cytosol to the membrane is a hallmark of its activation [25]. Upon PMA treatment, only PKCalpha and PKCdelta were translocated from the cytosolic to the particulate fraction. PKCbetaII, PKCepsilon, PKCtheta, PKCzeta, PKCiota, PKClambda, and PKCmu were not affected by PMA (Figure 2). PKCdelta was completely downregulated by proteolytic degradation by 6 h of treatment, while PKCalpha was translocated from the cytosolic to the particulate fraction between 3 h to 24 h of treatment. Hence, the data indicate that of the nine PKC isoforms expressed in RPE cells, only PKCalpha and PKCdelta were significantly activated by PMA stimulation.
###end p 40
###begin p 41
###xml 3 8 3 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 16 21 12 13 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#948;</sub>
###xml 79 80 71 72 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 380 385 368 369 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 393 398 377 378 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#948;</sub>
###xml 440 445 420 421 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#948;</sub>
###xml 532 537 508 509 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 661 666 633 634 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#948;</sub>
###xml 731 732 699 700 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 756 761 724 725 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
PKCalpha and PKCdelta, are the only isoforms translocated by PMA in RPE cells. A: Shown is a western blot analysis of the subcellular distribution between cytosolic and membrane fractions of the nine PKC isoforms expressed in RPE cells. RPE protein extracts were fractionated into cytosolic (C) and particulate (P) fractions; 80 microg of protein was loaded in each well. Only PKCalpha and PKCdelta were translocated in response to PMA. PKCdelta was completely downregulated by proteolytic degradation by 6 h of treatment, while PKCalpha was translocated from the cytosolic to the particulate fraction from 3 h to 24 h. Note that in the doublet obtained for PKCdelta, only the upper band (78 kDa) is the active form of the enzyme. B: Optical density of PKCalpha determined by densitometric imaging is shown (Mean+/-SD; n=4). The contents at different time points are statistically different (F=2.337, p<0.05). The beta-actin band with 42 kDa is used for quantitation.
###end p 41
###begin title 42
PKCalpha is necessary and sufficient to affect progression through the cell cycle
###end title 42
###begin p 43
###xml 28 33 28 29 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 41 46 37 38 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#948;</sub>
###xml 117 119 109 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r26">26</xref>
###xml 131 136 123 124 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 246 251 234 235 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
To differentiate between PKCalpha and PKCdelta, we used the conventional isoform-specific PKC agonist thymeleatoxin [26]. Since PKCalpha is the only one of the three isoforms that translocates, it is likely that this agonist would only affect PKCalpha.
###end p 43
###begin p 44
###xml 67 76 67 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3A</xref>
###xml 153 162 153 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1A</xref>
###xml 205 210 205 206 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 286 291 282 283 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#948;</sub>
###xml 313 322 305 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3B</xref>
Flow cytometry analysis of 100 nM thymeleatoxin-treated RPE cells (Figure 3A) showed a cell cycle progression profile similar to that obtained with PMA (Figure 1A). Western blot analysis confirmed that PKCalpha was specifically translocated (and activated) by thymeleatoxin, whereas PKCdelta remained unaffected (Figure 3B).
###end p 44
###begin p 45
###xml 3 8 3 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 71 72 67 68 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 243 244 239 240 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 282 287 278 279 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 448 453 440 441 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#948;</sub>
###xml 597 602 585 586 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 724 725 703 704 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 968 969 947 948 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 974 979 953 954 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 1123 1128 1098 1099 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 1271 1276 1242 1243 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 1311 1316 1278 1279 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 1362 1367 1325 1326 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
PKCalpha is necessary and sufficient to affect cell cycle progression. A: Flow cytometry analysis of RPE cells after 100 nM thymeleatoxin treatment shows a cell cycle progression profile similar to that obtained with PMA in eight experiments. B: western blot analysis shows that PKCalpha was rapidly translocated to the membrane by thymeleatoxin and downregulated within 24 h, the protein remained undetectable after 48 h of treatment, however, PKCdelta was not translocated and was not downregulated at all time points. Eighty micrograms of protein was loaded in each well. Optical density of PKCalpha determined by densitometric imaging is shown (Mean+/-SD, n=3). The beta-actin band with 42 kDa is used for quantitation. C: Flow cytometry analysis of RPE cells shows that there was no significant change in the cell cycle progression following PMA or thymeleatoxin restimulation when compared with the control over the 30 h time course after 48 h of PMA treatment. D: PKCalpha activity regulates the growth rate of RPE cells. Approximately 110,000 RPE cells were seeded and then incubated with thymeleatoxin or siRNA-PKCalpha for 24h. The numbers of cells were counted using a Coulter Counter and displayed in the top panel (* p<0.0001). Western blot using an anti-PKCalpha antibody showed that the total PKCalpha level was dramatically decreased in siRNA-PKCalpha treated cells; 40 microg of protein was loaded in each well.
###end p 45
###begin p 46
###xml 48 53 48 49 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 134 139 130 131 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 251 256 243 244 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 474 483 462 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3C</xref>
###xml 529 534 517 518 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 681 690 665 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3C</xref>
###xml 732 737 716 717 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 739 747 719 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
Further confirmation of the specific role of PKCalpha in the regulation of the cell cycle progression of RPE cells was provided by PKCalpha depletion experiments. RPE cells were pretreated with PMA for 48 h to deplete the cells of their endogenous PKCalpha. Cells were then restimulated with 100 nM PMA and 100 nM thymeleatoxin, and their distribution between the different phases of the cell cycle was analyzed between 0 and 30 h following restimulation by flow cytometry (Figure 3C). In the absence of a detectable level of PKCalpha, there was no significant change in the cell cycle progression of RPE cells following PMA or thymeleatoxin stimulation over the 30-h time course (Figure 3C), unlike the case of cells containing PKCalpha (Figure 1).
###end p 46
###begin p 47
###xml 19 24 19 20 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 151 156 147 148 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 334 339 326 327 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 416 425 404 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3D</xref>
###xml 452 457 440 441 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 549 554 533 534 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 627 636 607 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3D</xref>
###xml 764 769 744 745 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 916 921 892 893 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 973 978 945 946 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 840 845 <span type="species:ncbi:9606">human</span>
Although PKC or PKCalpha activation affects cell cycle progression, the proliferation of the PKC isoform involved has remained unclear. The role of PKCalpha in cell proliferation was further addressed using siRNA or thymeleatoxin. Equally seeded cultures were grown and counted, giving a direct reading of their growth rate. SiRNA-PKCalpha clones exhibited a growth rate of about half the rate of the control cells (Figure 3D), thus indicating that PKCalpha levels are directly proportional to the basal proliferation rate of RPE cells. However, PKCalpha agonist, thymeleatoxin, did not exhibit a growth rate of the RPE cells (Figure 3D), indicating that thymeleatoxin has no significant effect on cell proliferation. Altogether, the data strongly suggest that PKCalpha-specific activation is necessary and sufficient for the regulation of human RPE cells through the cell cycle. Moreover, our data indicate that PKCalpha affects RPE cell proliferation, since decreased PKCalpha expression correlates with decreased proliferation.
###end p 47
###begin title 48
###xml 3 7 3 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">kip1</sup>
p27kip1 mRNA and protein levels are downregulated following PKCalpha activation
###end title 48
###begin p 49
###xml 12 21 12 21 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f4">Figure 4A</xref>
###xml 26 31 26 27 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 102 107 98 99 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 229 234 221 222 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 501 506 489 490 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 540 643 524 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDK1, CDK2, CDK3, CDK4, Cyclin B1, Cyclin B2, Cyclin D2, Cyclin D3, Cyclin E1, Cyclin E2, p16, p18, p21</italic>
###xml 649 651 633 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 679 684 663 664 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 711 743 691 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CyclinA1, CyclinC, CyclinD1, p19</italic>
###xml 749 753 729 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p107</italic>
###xml 792 801 772 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f4">Figure 4B</xref>
###xml 1001 1012 981 992 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f4">Figure 4C,D</xref>
As shown in Figure 4A, PKCalpha can be downregulated at the 3-h time point following 24 h of siRNA-PKCalpha treatment, but not upregulated following PMA and thymeleatoxi treatment. To evaluate the molecular mechanism by which PKCalpha induces cell cycle progression, we used RT-PCR to examine the transcript levels of cell cycle-regulatory proteins after 3 h of treatment. We found that p27 mRNA was obviously downregulated following PMA or thymeleatoxin treatment, and upregulated following siRNA-PKCalpha treatment. Levels of other mRNA (CDK1, CDK2, CDK3, CDK4, Cyclin B1, Cyclin B2, Cyclin D2, Cyclin D3, Cyclin E1, Cyclin E2, p16, p18, p21, and Rb) remained unaffected by PKCalpha activation. The mRNAs for CyclinA1, CyclinC, CyclinD1, p19, and p107, could not be detected in this assay (Figure 4B). During 24 h of stimulation with PMA or thymeleatoxin, p27 mRNA was strongly and rapidly downregulated at 1, 2, and 6 h following PMA treatment, or at 1 h and 2 h following thymeleatoxin treatment (Figure 4C,D).
###end p 49
###begin p 50
###xml 25 29 25 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 48 53 48 49 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 66 67 62 63 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 72 77 68 69 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 150 155 142 143 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 273 274 261 262 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 279 283 267 271 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">kip1</sup>
###xml 413 418 401 402 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 507 508 491 492 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 721 722 705 706 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
Downregulation of the p27Kip1 gene following PKCalpha activation. A: PKCalpha mRNA level is downregulated at the 3 h point following 24 h of siRNA-PKCalpha (lane 2) treatment, but not upregulated following PMA (lane 4) and thymeleatoxi (lane 3) treatment. lane 1, control. B: p27kip1 mRNA level is downregulated following 3 h of PMA (lane 4) and thymeleatoxi (lane 3) treatment and upregulated following siRNA-PKCalpha (lane 2) treatment. lane 1, control. Five micrograms of RNA was used for each reaction. C: RT-PCR analysis of RPE cells stimulated with 24 h PMA and thymeleatoxin treatment shows a strong downregulation of the p27 mRNA at 1, 2, and 6 h following PMA, or at 1 and 2 h following thymeleatoxin treatment. D: Optical density of P27 mRNA determined by densitometric imaging is shown (Mean+/-SD, n=4). The GAPDH band is used for quantitation.
###end p 50
###begin p 51
###xml 157 165 157 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f5">Figure 5</xref>
###xml 381 385 381 385 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">kip1</sup>
###xml 456 461 456 457 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
Consistent with a change at the mRNA level, the p27 protein was also downregulated over a 24-h period following PMA or thymeleatoxin treatment of RPE cells (Figure 5). In untreated RPE cells, the p27 protein level remained constant, while in cells treated either with PMA or thymeleatoxin, p27 was strongly downregulated at the 1 h and 3 h time points. These data indicate that p27kip1 is the only cell cycle-regulatory molecule downregulated following PKCalpha activation.
###end p 51
###begin p 52
###xml 25 29 25 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 51 56 51 52 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 69 70 65 66 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 358 359 350 351 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
Downregulation of the p27Kip1 protein following PKCalpha activation. A: Western blot analysis of RPE cells treated 24 h with 100 nM PMA and 100 nM thymeleatoxin reveals a strong downregulation of the p27 protein at the 1 h and 3 h time points. Gels show representative results of four independent experiments. Each well was loaded with 40 microg of protein. B: Optical density of P27 protein determined by densitometric imaging is shown (Mean+/-SD, n=4). The beta-actin band with 42 kDa is used for quantitation.
###end p 52
###begin title 53
###xml 40 45 40 41 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
Immunofluorescence colocalization of PKCalpha and P27
###end title 53
###begin p 54
###xml 133 141 133 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f6">Figure 6</xref>
###xml 146 151 146 147 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 391 396 387 388 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 442 447 434 435 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 545 550 533 534 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
Confocal microscopy clearly showed that the cultured RPE cells formed monolayers with typical polygonal cellular arrays. As shown in Figure 6, PKCalpha and p27 have obvious cytoplasmic localizations and slight nuclear localization, and mostly colocalized in the cytoplasm of the cells. Although minor staining differences appeared among 100 nM PMA, 100 nM thymeleatoxin, and 100 nM siRNA-PKCalpha when compared with that of control group, PKCalpha and p27 seemed colocalized in the cytoplasm of the cells with decreased cell numbers in siRNA-PKCalpha.
###end p 54
###begin p 55
###xml 30 35 30 31 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 67 72 63 64 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 256 261 248 249 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 266 271 254 255 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 354 359 338 339 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
Confocal images of p27 and PKCalpha colocaliztion in RPE cells. PKCalpha and p27 have obvious cytoplasmic localizations and slight nuclear localization, and mostly colocalized in the cytoplasm of the cells stimulated with PMA, thymeleatoxin, and siRNA- PKCalpha. PKCalpha (FITC, green label) p27 (Cy3, red label), nuclei (Hotchest 33342, blue label), PKCalpha, and p27 colocalization (yellow label).
###end p 55
###begin title 56
Discussion
###end title 56
###begin title 57
Effect of PKCalpha on the cell cycle progression in RPE cells
###end title 57
###begin p 58
###xml 233 235 233 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 347 349 347 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 350 352 350 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 397 402 397 398 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 527 532 523 524 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 329 336 <span type="species:ncbi:9986">rabbits</span>
We have found that PKC activation by phorbol esters affected RPE cell progression through the cell cycle. This was consistent with previous data showing the correlation between the results on PKC activity and RPE cell proliferation [10] and the animal results that demonstrated inhibitors of PKC hypericin could have efficacy in rabbits with PVR [16,17]. Moreover, we have determined that only PKCalpha activation is necessary and sufficient to regulate cell cycle progression of RPE cells, and that the expression level of PKCalpha correlates with the proliferation of RPE cells.
###end p 58
###begin p 59
###xml 111 112 111 112 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 145 146 145 146 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 161 163 161 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r27">27</xref>
###xml 164 166 164 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r29">29</xref>
###xml 201 202 201 202 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 446 447 446 447 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 458 459 458 459 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
It is well known that PKC has been associated with the regulation of cell cycle progression either during the G1-to-S progression or during the G2/M transition [27-29]. PKC has been shown to regulate G1 progression through the modulation of CDK activity, either by modifying cyclin or CDK expression levels, or by modifying the expression of the cyclin-CDK inhibitors. Due to the relevance of PKC isozymes in the control of cell cycles, both in G1/S and in G2/M, the elucidation of such complex intracellular networks using cellular and animal models has become of the outmost importance.
###end p 59
###begin p 60
###xml 77 79 77 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 80 82 80 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r30">30</xref>
###xml 83 85 83 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r31">31</xref>
###xml 137 142 137 138 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 176 177 172 173 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 224 225 220 221 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 315 317 311 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 522 526 518 522 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 539 541 535 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r32">32</xref>
###xml 750 752 746 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r33">33</xref>
###xml 923 925 919 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r34">34</xref>
###xml 547 552 <span type="species:ncbi:9606">human</span>
Predominantly, PKC plays an inhibitory role in many cell cycle progressions [23,30,31]. In intestinal epithelial cells, for instance, PKCalpha-specific activation resulted in G1 arrest and delayed transit through the S and G2/M phases through an upregulation of p21 and p27, resulting in hypophosphorylation of Rb [23]. However, in contrast to most cell types, phorbol esters accelerated growth factor-induced Swiss 3T3 cell cycle entry and progression into the S phase by elevating cyclin D1 levels and downregulating p27Kip1 expression [32]. In human RPE cells, ethambutol may exert toxic effects in RPE, including the suppression of cell growth, formation of cytoplasmic vacuoles, and reduction of phagocytic functions via the PKC signal pathway [33]. Alkylphosphocholines inhibit proliferation of RPE cells and RPE-mediated matrix contraction in vitro at nontoxic concentrations through the inhibition of PKC activity [34].
###end p 60
###begin p 61
###xml 79 84 79 80 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 114 115 110 111 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 171 180 167 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1A</xref>
###xml 185 194 181 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3A</xref>
###xml 268 277 264 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3D</xref>
###xml 349 354 345 346 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 449 451 441 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r35">35</xref>
###xml 452 454 444 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r39">39</xref>
###xml 477 482 469 470 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 137 142 <span type="species:ncbi:9606">human</span>
Our study is the first to show that the activation of PKC, and specifically PKCalpha, exerts effects on the S to G2/M progression of the human RPE cell cycle, as shown in Figure 1A and Figure 3A, and that the inhibition of PKC decreases the proliferation, as shown in Figure 3D. Recently, aprinocarsen, an antisense oligonucleotide (ASO) against PKCalpha, has been used to decrease the malignant proliferation in clinic trials in different cancers [35-39]. Similarly, since PKCalpha was the only isoform associated with the proliferation of RPE cells in our study, it may be a rational approach for targeted therapies against RPE cell proliferation and PVR disease.
###end p 61
###begin title 62
###xml 22 26 22 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">kip1</sup>
###xml 40 45 40 41 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
Downpregulation of p27kip1 following PKCalpha activation in RPE cells
###end title 62
###begin p 63
###xml 250 255 250 251 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 286 290 282 286 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">kip1</sup>
###xml 432 434 428 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r40">40</xref>
###xml 435 437 431 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r41">41</xref>
To elucidate the mechanism by which PKC increased the RPE cell cycle progression, we analyzed the expression of various cell cycle-regulatory proteins following PKC activation. We found that the only cell cycle regulatory protein downregulated by PKCalpha activity was the inhibitor p27kip1, which has been proposed to be part of a cell-intrinsic timer that arrests the cell cycle and initiates differentiation in several lineages [40,41].
###end p 63
###begin p 64
###xml 113 117 113 117 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">kip1</sup>
###xml 124 126 124 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r42">42</xref>
###xml 127 129 127 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r47">47</xref>
###xml 397 399 397 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r44">44</xref>
###xml 721 723 721 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r45">45</xref>
###xml 724 726 724 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r46">46</xref>
###xml 764 768 764 768 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">kip1</sup>
###xml 825 829 825 829 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">kip1</sup>
###xml 1090 1092 1090 1092 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r47">47</xref>
###xml 1140 1144 1140 1144 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">kip1</sup>
###xml 1251 1255 1251 1255 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">kip1</sup>
###xml 1280 1285 1280 1281 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 1355 1359 1351 1355 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">kip1</sup>
###xml 1367 1372 1363 1364 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 1415 1423 1407 1415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f6">Figure 6</xref>
###xml 1453 1458 1445 1446 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 1569 1573 1557 1561 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">kip1</sup>
###xml 1625 1630 1613 1614 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#948;</sub>
###xml 73 77 <span type="species:ncbi:10090">mice</span>
###xml 778 782 <span type="species:ncbi:10090">mice</span>
Several groups have reported gigantism and multiple organ hyperplasia in mice with targeted disruption of the p27kip1 gene [42-47]. Some of the most dramatic phenotypic changes in these animals were involved in the retina. For example, Nakayama et al. reported that the RPE exhibited an increase in thickness in its apical to basal dimension compared to that seen in the congenic C57BL/6J strain [44]. Other results showed that the neural retina exhibited focal areas of dysplasia, attributed to extended histogenesis of photoreceptors and Muller cells and to the displacement of reactive glia into the layer of photoreceptor outer segments, leading to a disruption in the normal organization of the outer nuclear layer [45,46].  et al. examined the retinas of p27kip1 knockout mice in more detail and not only found that p27kip1 was an important factor in regulating RPE proliferation during development, but also observed that this protein may be a crucial factor involved in generating appropriately polarized epithelial cells and in the construction of the photoreceptor-RPE interface [47]. From these results, it was concluded that p27kip1 downregulation may be involved in the process of RPE cell proliferation and PVR disease. In our study, p27kip1 was downregulated by PKCalpha activation at the gene and protein levels in RPE cells. Moreover, p27kip1 and PKCalpha colocalized within the cells, as shown in Figure 6. Therefore, inhibitors of PKCalpha could have antiproliferative effects on RPE cells in vitro and as a potential therapeutic drug for PVR via p27kip1 downregulation. In addition, a possible role of PKCdelta in cell cycle progression and proliferation in RPE cells should be ruled out in the future study.
###end p 64
###begin p 65
###xml 106 108 106 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r48">48</xref>
###xml 109 111 109 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r50">50</xref>
###xml 256 261 256 257 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 266 270 262 266 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">kip1</sup>
###xml 298 306 294 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f7">Figure 7</xref>
On the other hand, several studies have reported the PKC-induced upregulation of p27 in other cell types [48-50]; however, this was associated with cell cycle blocks, unlike the case for RPE cells reported here. Taken together, the relationship between PKCalpha, p27kip1, and PVR is illustrated in Figure 7.
###end p 65
###begin p 66
###xml 26 31 26 27 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 54 59 50 51 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 146 150 138 142 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">kip1</sup>
###xml 98 103 <span type="species:ncbi:9606">human</span>
Proposed mechanisms of PKCalpha regulation on PVR. PKCalpha affects cell proliferation and PVR in human RPE cells through negative feedback of p27kip1.
###end p 66
###begin p 67
It is well known that PVR is a result of various biologic reactions, such as the synthesis of the extracellular matrix, contraction of membranes, and apoptotic change of photoreceptors. Of all the cells involved in PVR, the RPE cell is a central player, but the inhibition of RPE cell proliferation is not sufficient to inhibit PVR, which has been proven by studies of anticancer drugs for PVR since the 1990s.
###end p 67
###begin p 68
###xml 34 39 34 35 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 139 143 135 139 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">kip1</sup>
###xml 175 180 171 172 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
In summary, we have found that PKCalpha affects the cell cycle progression and proliferation in RPE cells through the downregulation of p27kip1. These results suggest that PKCalpha can be used as a potential therapeutic target against RPE cell proliferation and PVR disease.
###end p 68
###begin title 69
Acknowledgments
###end title 69
###begin p 70
This study was supported by the National Nature Science Foundation of China (30200306), New Century Excellent Talent Grant (NCET-07-0876), and National High-tech R&D Program of China (863 Program, 2009AA2Z404).
###end p 70
###begin title 71
References
###end title 71
###begin article-title 72
The role of protein kinase C isoenzymes in the regulation of cell proliferation and differentiation.
###end article-title 72
###begin article-title 73
Studies and perspectives of protein kinase C.
###end article-title 73
###begin article-title 74
The molecular heterogeneity of protein kinase C and its implications for cellular regulation.
###end article-title 74
###begin article-title 75
The structure, expression, and properties of additional members of the protein kinase C family.
###end article-title 75
###begin article-title 76
PKCu is a novel, atypical member of the protein kinase C family.
###end article-title 76
###begin article-title 77
The potential for isoenzyme-selective modulation of protein kinase C.
###end article-title 77
###begin article-title 78
Protein kinase C and lipid signaling for sustained cellular responses.
###end article-title 78
###begin article-title 79
Growth regulation of retinal pigment epithelial (RPE) cells in vitro.
###end article-title 79
###begin article-title 80
Hypericin inhibits cell growth and induces apoptosis in retinal pigment epithelial cells: possible involvement of protein kinase C.
###end article-title 80
###begin article-title 81
Interferon beta affects retinal pigment epithelial cell proliferation via protein kinase C pathways.
###end article-title 81
###begin article-title 82
###xml 66 71 <span type="species:ncbi:9031">chick</span>
Involvement of the protein kinase pathway in melanin synthesis by chick retinal pigment epithelial cells.
###end article-title 82
###begin article-title 83
Migration of retinal pigment epithelium cells in vitro is regulated by protein kinase C.
###end article-title 83
###begin article-title 84
###xml 42 47 <span type="species:ncbi:9606">human</span>
Transforming growth factor-beta regulates human retinal pigment epithelial cell phagocytosis by influencing a protein kinase C-dependent pathway.
###end article-title 84
###begin article-title 85
Cytokine effect on fibronectin release by retinal pigment epithelial cells.
###end article-title 85
###begin article-title 86
###xml 63 68 <span type="species:ncbi:9606">human</span>
The inhibition of Ca2+ influx induced by hypericin in cultured human retinal pigment epithelial cells analyzed by confocal imaging.
###end article-title 86
###begin article-title 87
The antidepressant hypericin inhibits progression of experimental proliferative vitreoretinopathy.
###end article-title 87
###begin article-title 88
###xml 69 76 <span type="species:ncbi:9986">rabbits</span>
Effects of hypericin on traumatic proliferative vitreoretinopathy in rabbits.
###end article-title 88
###begin article-title 89
Tissue and cellular distribution of the extended family of protein kinase C isoenzymes.
###end article-title 89
###begin article-title 90
Protein kinase C isoenzyme expression in retinal cells.
###end article-title 90
###begin article-title 91
###xml 52 57 <span type="species:ncbi:9606">human</span>
Expression of protein kinase C isoforms in cultured human retinal pigment epithelial cells.
###end article-title 91
###begin article-title 92
Protein expression profiling identifies macrophage migration inhibitory factor and cyclophilin a as potential molecular targets in non-small cell lung cancer.
###end article-title 92
###begin article-title 93
###xml 112 116 <span type="species:ncbi:9823">pigs</span>
Western blotting for detection of glucocorticoid receptors in the brain and pituitary gland from adrenal intact pigs.
###end article-title 93
###begin article-title 94
Protein kinase C isozyme-mediated cell cycle arrest involves induction of p21(waf1/cip1) and p27(kip1) and hypophosphorylation of the retinoblastoma protein in intestinal epithelial cells.
###end article-title 94
###begin article-title 95
Involvement of p21(Waf1/Cip1) in protein kinase C alpha-induced cell cycle progression.
###end article-title 95
###begin article-title 96
Regulation of protein kinase C.
###end article-title 96
###begin article-title 97
Characterization of ligand and substrate specificity for the calcium-dependent and calcium-independent protein kinase C isozymes.
###end article-title 97
###begin article-title 98
The role of protein kinase C in G1 and G2/M phases of the cell cycle
###end article-title 98
###begin article-title 99
Linking protein kinase C to cell-cycle control.
###end article-title 99
###begin article-title 100
Protein kinase C and prostate carcinogenesis: targeting the cell cycle and apoptotic mechanisms.
###end article-title 100
###begin article-title 101
Regulation of the cell cycle at the G2/M boundary in metastatic melanoma cells by 12-O-tetradecanoyl phorbol-13-acetate (TPA) by blocking p34cdc2 kinase activity.
###end article-title 101
###begin article-title 102
Cell cycle arrest in the G2 phase induced by phorbol ester and diacylglycerol in vascular endothelial cells.
###end article-title 102
###begin article-title 103
Differential control of cyclins D1 and D3 and the cdk inhibitor p27Kip1 by diverse signalling pathways in Swiss 3T3 cells.
###end article-title 103
###begin article-title 104
###xml 76 81 <span type="species:ncbi:9606">human</span>
Ethambutol induces PKC-dependent cytotoxic and antiproliferative effects on human retinal pigment cells.
###end article-title 104
###begin article-title 105
###xml 46 51 <span type="species:ncbi:9606">human</span>
Alkylphosphocholines inhibit proliferation of human retinal pigment epithelial cells.
###end article-title 105
###begin article-title 106
The role of protein kinase C-alpha (PKC-alpha) in cancer and its modulation by the novel PKC-alpha-specific inhibitor aprinocarsen.
###end article-title 106
###begin article-title 107
Effect of protein kinase C inhibitors on porcine oocyte activation.
###end article-title 107
###begin article-title 108
###xml 157 165 <span type="species:ncbi:9606">patients</span>
A phase I trial of aprinocarsen (ISIS 3521/LY900003), an antisense inhibitor of protein kinase C-alpha administered as a 24-hour weekly infusion schedule in patients with advanced cancer.
###end article-title 108
###begin article-title 109
###xml 97 105 <span type="species:ncbi:9606">patients</span>
Randomized phase II evaluation of aprinocarsen in combination with gemcitabine and cisplatin for patients with advanced/metastatic non-small cell lung cancer.
###end article-title 109
###begin article-title 110
The role of protein kinase C-alpha in malignancies of the nervous system and implications for the clinical development of the specific PKC-alpha inhibitor aprinocarsen.
###end article-title 110
###begin article-title 111
p27Kip1 alters the response of cells to mitogen and is part of a cell-intrinsic timer that arrests the cell cycle and initiates differentiation.
###end article-title 111
###begin article-title 112
A cell-intrinsic timer that operates during oligodendrocyte development.
###end article-title 112
###begin article-title 113
###xml 124 128 <span type="species:ncbi:10090">mice</span>
A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice.
###end article-title 113
###begin article-title 114
###xml 19 23 <span type="species:ncbi:10090">mice</span>
Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1).
###end article-title 114
###begin article-title 115
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice lacking p27Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors.
###end article-title 115
###begin article-title 116
p27Kip1 regulates cell cycle withdrawal of late multipotent progenitor cells in the mammalian retina.
###end article-title 116
###begin article-title 117
Control of Muller glial cell proliferation and activation following retinal injury.
###end article-title 117
###begin article-title 118
###xml 90 94 <span type="species:ncbi:10090">mice</span>
Defects in retinal pigment epithelium cell proliferation and retinal attachment in mutant mice with p27(Kip1) gene ablation.
###end article-title 118
###begin article-title 119
###xml 96 101 <span type="species:ncbi:10090">mouse</span>
Dopamine regulates cell cycle regulatory proteins via cAMP, Ca(2+)/PKC, MAPKs, and NF-kappaB in mouse embryonic stem cells.
###end article-title 119
###begin article-title 120
Differential role for protein kinase C-mediated signaling in the proliferation of medulloblastoma cell lines.
###end article-title 120
###begin article-title 121
###xml 53 58 <span type="species:ncbi:9606">human</span>
Inositol hexaphosphate (IP6) blocks proliferation of human breast cancer cells through a PKCdelta-dependent increase in p27Kip1 and decrease in retinoblastoma protein (pRb) phosphorylation.
###end article-title 121

